Contact
DMCA
Privacy
Robuta
https://www.cliniexpert.com/article/946.html
FDA Approves Wyost (denosumab-bddz), an Interchangeable Biosimilar to Xgeva-CliniExpert
Sandoz, the global leader in generic and biosimilar medicines, today announced that the US Food and Drug Administration (FDA) approved Wyost (denosumab-bbdz),...
fda
wyost
denosumab
interchangeable
biosimilar